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Abstract 
Paediatric intramedullary spinal cord lesions are 
uncommon pathologies, prone to result in dismal 
prognosis if not managed promptly and aggressively. 
While children usually present in good functional grades 
compared to adults, early recognition and treatment is 
important to improve outcomes. In this review, we 
present tumour demographics, patient factors, and 
treatment modalities of intramedullary spinal cord lesions 
in paediatric patients.  
Keywords: intramedullary spinal cord tumors, pediatric, 
ependymoma, astrocytoma 
Introduction 
Tumours of the Central Nervous System (CNS) are the 
second most common malignancies in children, after 
leukaemias.1 Intramedullary spinal cord tumours (IMSCT), 
however, are uncommon and account for only 3-10% of 
all CNS tumours, and 30-40% of all spinal cord tumours in 
the paediatric population.1-5 These tumours can be 
localized or holocord — the latter involving almost the 
entire spinal cord from the cervico-medullary junction to 
the conus medullaris, and representing a rarer and more 
challenging condition to treat.2,4 Clinically, the tumours 
present insidiously, are slowly progressive, and may lead 
to profound neurologic deficits.2  
Low grade astrocytoma represents most of the childhood 
IMSCT, closely followed by ependymomas, 
haemangioblastomas and gangliogliomas — the latter 
more common below age three.2,6 Developmental 
tumours such as teratoma, dermoid and epidermoid cysts 
are rarer, occurring mostly during first year of life.2 With 
advancement in radiology, intraoperative monitoring and 
surgical technique; safe and effective treatment strategies 
for these tumours are now available.3,4 Surgery remains 
the mainstay of treatment and may or may not be 
supplemented by adjuvant therapy.1 Most of the available 
evidence on the management of IMSCT in children is 
based on case series, limiting our ability to completely 
understand tumour demographics and outcomes.4  
Herein, we have reviewed the literature to assess the 
incidence, clinical and radiological characteristics, and 
management strategies in children with IMSCT and other 
spinal cord lesions.  
Review of Evidence 
In one of the most cited case series of IMSCT published in 
1996, Constantini et al., carried out a retrospective analysis 
of 27 children under 3 years of age, who presented with 
IMSCT at their centre. They reported pain to be the 
commonest presenting symptom, followed by motor 
weakness, torticollis, and progressive kyphoscoliosis. 
Gross total resection (GTR) was achieved in 72% of the 
cases, and no surgical mortality was reported. Twenty-four 
low-grade (LG) lesions were observed on histopathology, 
with astrocytoma being the commonest (n= 12). Out of 
the three reported high-grade (HG) lesions, two were 
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Figure-1: T1 weighted MR image, sagittal section of cervical spine of a 15 years old 
girl, showing loss of cervical lordosis, and a hypo-intense signal change in the spinal 
cord, extending from C3 till C6, with swelling of the cord.
anaplastic astrocytoma, and one glioblastoma. 
Encouraging functional outcomes were seen at 76 months 
of follow-up, concluding that IMSCT can be radically and 
safely removed in children less than 3 years of age.2,6 
In 2012, Bansal et al., carried out a retrospective analysis of 
82 paediatric patients with IMSCTs, out of which 69.5% 
were males (n=57). Epidermoid cysts constituted the 
most common type of tumour, followed by low-grade 
gliomas and ependymoma. Ependymomas had a higher 
amenability for GTR as compared to pilocytic astrocytoma 
(43.7% vs. 22.2% respectively). Near-total resection was 
achieved for most other pathologies. At the last follow-
up, most patients had improved (n=8) or unchanged (n= 
46) functional status, while two patients had worsened. 
The authors concluded that pre-operative neurological 
status was more predictive of post-operative functional 
outcomes than histological grading.7 
Babu et al., published a retrospective analysis in 2014, of 46 
patients treated for astrocytoma of the spinal cord at their 
center. The median age was 15 years, with a male 
predominance observed. Pilocytic astrocytoma was the 
commonest pathology (41.6%), followed by grade 2 diffuse 
astrocytoma (21.7%), anaplastic astrocytoma grade 3 
(19.6%) and glioblastoma in the rest. Most patients 
presented with pain (45.7%), while dysesthesia/paresthesia 
and scoliosis constituted the rest of the presenting 
symptoms. While surgery was the mainstay of treatment, 
GTR could only be achieved in 12.5% of the patients. The 
study revealed a direct relationship between high tumour 
grade, radical resection and significant post-operative 
neurological deficits.8 
In another retrospective series by Ahmed et al., 55 
children with IMSCT were reviewed. Most children 
presented with sensory deficit, with cervicomedullary 
junction the commonest site on radiology. Low-grade 
astrocytoma was the commonest pathology (53%), 
followed closely by ependymoma. Most children 
underwent sub-total resection for their tumours (62%), 
followed by an additional procedure of shunt insertion in 
22 patients, for post-operative hydrocephalus. While no 
surgical mortality was observed, 27% patients reportedly 
developed new or progressive neurological deficit and 
47% had a recurrence of the tumour, at a mean of three 
months after surgery. Extent of resection and tumour 
grade were conclusively reported to influence patient 
outcomes.9 In 2015, Kutluk et al., evaluated the pathologic 
factors and treatment modalities in paediatric patients 
with IMSCTs. In their retrospective review of 36 patients, 
aged 7.9 years on average, they reported ependymoma 
(52.8%), and astrocytoma (44.4%) as the commonest 
tumours. Only three high grade tumours were reported. 
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Figure-2: T2 weighted MR image of the same girl, showing a hyperintense, sausage 
shaped intramedullary lesion, extending from C3 to C6. It is causing expansion of the 
spinal cord, and there are hyperintense signal changes in the cord, proximal and distal 
to the lesion. Figure-3: T1 post-contrast image of the same girl, showing subtle peripheral 
enhancement. This lesion was resected, and histopathology was reported as diffuse 
astrocytoma grade II.
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The tumour was primarily located in the thoracic (47%) 
and cervical (28%) segments, and surgery was the 
mainstay of treatment, with STR and GTR achieved in 
most patients (45% and 33% respectively). Adjuvant 
radiation and chemotherapy was used to supplement 
treatment in 26 and 15 patients, respectively. The 3, 5 and 
10 year overall survival rates were 72%, 63% and 56%, and 
event free survival rates were 43%, 40% and 40%, 
respectively. The authors reported significantly higher 
survival rates in patients with low grade tumours, 
especially those in the ependymoma group.1 
Luksik et al., carried out a large retrospective assessment, 
exploring factors that may influence survival in 348 
paediatric patients with spinal cord astrocytoma, 
recorded in the surveillance, epidemiology, and end 
result (SEER) database. Average age for the group was 9.3 
years, with a gender predominance for males. Tumours 
were majorly WHO grade 2 (20.7%) followed by grades 4, 
1, and 3 tumours. Surgery was the primary treatment 
modality, with partial resection achieved in 51.7% of the 
patients and gross total resection in 28.7%. Radiotherapy 
followed as an adjunct in 28.4% patients and the survival 
rate for patients at 5 years was 74.8%. Surgical 
intervention, especially with GTR, improved survival, 
while high grade lesions, application of radiation therapy, 
and distant and invasive extension of the tumour 
significantly decreased survival. Younger age was shown 
to have a protective effect. The authors conclusively 
highlighted the need for early diagnosis for better 
prognosis.10 In another major study in 2019, Bhimani et 
al., analyzed the Paediatric American College of Surgeons 
National Surgical Quality Improvement Programme 
database, retrospectively for acute surgical risk. In the 
group of 139 patients from the registry, predominantly 
males (n= 81), and at a mean age of 8.7 years, tumours 
mostly arose from the thoracic spine, followed by the 
cervical and lumbar spinal regions. Worse preoperative 
health status, and a greater proportion of malignant 
tumours were noticed with cervical and thoracic IMSCT 
populations compared with the lumbar IMSCT 
population. Of the 12 readmissions, patients with cervical 
IMSCTs returned to the operating room at a significantly 
greater rate than did the thoracic and lumbar IMSCT 
populations, mainly due to respiratory problems and 
hydrocephalus management. However, the overall acute 
surgical risk reportedly remained low.11 
Conclusion 
Astrocytoma and ependymoma, predominantly low-
grade, constitute the most common intramedullary 
IMSCT in children. While modern surgical adjuncts such as 
microscopes and intra-operative monitoring have 
resulted in improved outcomes over the years, 
preoperative neurologic status, remains the most 
important predictive factor of prognosis in children, even 
more so than tumour grade.  
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